• No CET Points

     


    In this edition of Advances in Eyecare, we hear from four experts about developments in treatments, assessments and our understanding of human vision. 

    Prof John Flanagan talks about a potential new treatment for glaucoma and explains the neuroprotective role of lipoxin around ganglion cells and how maintenance of this may offer new options in management of the disease.

    Dr Kathleen Vancleef discusses the ASTEROID project’s new technology, and how its new methodology promises to make the assessment of younger patients easier. 

    Dr Vivek Nityananda offers a unique insight into how we may better understand human stereo vision through his research into the stereo vision of praying mantises as part of the ‘Man, mantis and machine: the computation of 3D vision’ project.

    Prof Jenny Read, Principal Investigator on the ASTEROID project and ‘Man, mantis and machine: the computation of 3D vision’, talks virtual reality and 3D displays, and the potential impact of prolonged use of virtual reality displays upon the visual system.


    • Professor John Flanagan interviewed by Geoff Watts

      Glaucoma, in its various forms, is a leading cause of blindness in the world according to the World Health Organisation. The disease has no current cure and medical intervention is still focused upon the management of intraocular pressure. However, many who receive treatment still experience loss of vision. Professor John Flanagan, Dean and Professor of Optometry at the University of California Berkeley, discusses a potential new treatment for glaucoma which is centred around a better understanding of the disease at a cellular level.

    Learning objectivesUnit 2 - Accurate stereo test for mobile device (ASTEROID) (~10 mins)